A new map highlights the UK regions where women younger than 50 face the highest probability of receiving a late-stage breast cancer diagnosis. In certain regions, young individuals faced a likelihood more than four times greater of discovering their cancer at stage three or four, a point where the condition has disseminated through the body and complicates treatment.
Annual UK statistics show approximately 55,500 women and 400 men receive a breast cancer diagnosis. A sixth of these occurrences happen in females under 50 who fall outside the scope of the NHS breast screening initiative. Regular mammogram invitations begin following a woman's fiftieth birthday and recur triennially until age 71, meaning younger individuals must spot physical signs like lumps, dimpling, or nipple discharge to seek medical evaluations. Furthermore, younger demographics tend to develop more aggressive breast cancer variants.
CoppaFeel!, a breast cancer awareness charity, warns of sharp geographic disparities regarding when young women receive their diagnoses. Birmingham and Solihull recorded the highest rate on the charity's list of late diagnosis areas, with 30 per cent of females under 50 identified at stage three or four. Conversely, Cornwall and the Isles of Scilly saw this happen to only 7 per cent of patients under 50. An additional 19 areas saw over 20 per cent of women in this age cohort receive late-stage diagnoses, including Lincolnshire, Coventry and Warwickshire, Greater Manchester, London, Gloucestershire, Norfolk, Cumbria, Kent, Yorkshire, and Northamptonshire.
Sophie Dopierala-Bull, director of services and engagement at CoppaFeel!, stated that the quantity of young females getting late-stage diagnoses remains unacceptably high. She noted that breast cancer is still treated too much like an older person's disease with women telling us they are dismissed as too young when they first ask for help. Every late diagnosis represents a missed opportunity to treat the cancer before it spreads and becomes more difficult to treat.
Signs of breast cancer and the importance of screenings
Signs and symptoms of breast cancer include:
- A lump or swelling in the breast, upper chest or armpit
- A change to the skin, such as puckering or dimpling
- A change in the colour of the breast - the breast may look darker, red or inflamed
- A nipple change, for example it has become pulled in (inverted)
- Rash or crusting around the nipple
- Unusual liquid (discharge) from either nipple
- Changes in size or shape of the breast
On its own, pain in your breasts is not usually a sign of breast cancer.
But look out for pain in your breast or armpit that's there all or almost all the time.
One million people are missing screenings
Thousands of women may be living with undetected breast cancer after missing screening appointments.
The NHS warned about a third of eligible patients did not accept the free test offer last year.
Figures show that was just over one million people, and 2.2 million have missed an appointment in the past three years.
An estimated one in 100 women are diagnosed with cancer after screening.
In 2023 there were 18,942 tumours detected out of 1.93 million women screened for breast cancer, but a further 1.05 million women who were invited did not attend.
The one per cent detection rate means there were potentially 10,000 missed cases.
Screening is generally offered to women every three years between the ages of 50 and 71, when their risk increases.
Scans are carried out in local clinics and hospitals, as well as in roving scan vans in some places.
Women who have had a mammogram should still check their breasts regularly.
The fact that there are more late diagnoses in young people in some areas of the country than others points to systemic gaps in early detection and awareness for younger people, Dopierala-Bull added. It also highlights the need for more research to understand these barriers and address them.
Sarah Hughes, managing director of West Midlands Cancer Alliance, stated that cancer respects no age limits, noting that a very significant number of women aged under 50 receive a breast cancer diagnosis daily and that it serves as the primary cause of cancer-related deaths among females aged 25 to 49.
Patients diagnosed at stages one and two demonstrate higher five-year survival metrics. Northamptonshire registered the lowest survival rates, where 82.1 per cent of all-age patients lived five years or longer post-diagnosis, compared to 90.6 per cent in Suffolk and North East Essex. Within Wales, five-year survival drops by 5 to 8 per cent in deprived communities versus affluent ones. CoppaFeel! urged the implementation of targeted risk-based screenings for younger women following the data release.
ASK DR ZOE
THE SUN'S RESIDENT GP DR ZOE WILLIAMS SAYS...
Do you have a question you wish you could ask a doctor?
Whether you are worrying about a new symptom, stuck on a long NHS waiting list, or struggling to get a face-to-face appointment with your GP, I am here to help guide you through it.
Whatever is on your mind, send an email to health@thesun.co.uk.
Perhaps you have recently received a confusing new diagnosis, have questions about a newly prescribed medication, or are simply feeling anxious about a partner's declining health and don't know where to turn.
I will do my best to help answer your question anonymously.
I answer readers every week in the Sun on Sunday, and in Sun Health on a Tuesday. Find my previous answers online, here.
Get in touch!
The challenge for anyone under 50 is that there is no screening programme to detect breast cancer, Sophie explained. More than half of breast cancer diagnoses occur outside the current screening age, with one in six breast cancer cases occurring in under-50s in the UK. This means being diagnosed is solely reliant on people being able to identify the symptoms themselves, feeling confident enough to go to their GP, and then being listened to by that GP when they go. Quite simply, there are too many variables, and risk-based screening would alter this.
The charity urged the Government to pilot risk-based screenings and educate younger women on warning signs and help-seeking behaviors during routine health checks to improve outcomes for under-50s without major expenses. Specifically, the organization requested government trials for risk-based screenings targeting women aged 18 to 49. Instead of depending purely on age, high-risk individuals would be identified through family history evaluations, saliva tests, and breast density measures to receive earlier or more frequent appointments. CoppaFeel! also advocated for incorporating breast awareness into standard NHS visits, such as cervical screenings, HPV vaccinations, and health checks, instructing women on self-examinations and when to seek medical support.
